KEVZARA Trademark

Trademark Overview

On Monday, September 15, 2014, a trademark application was filed for KEVZARA with the United States Patent and Trademark Office. The USPTO has given the KEVZARA trademark a serial number of 86394577. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, October 29, 2025. This trademark is owned by Sanofi. The KEVZARA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis and ankylosing spondylarthritis
kevzara

General Information

Serial Number86394577
Word MarkKEVZARA
Filing DateMonday, September 15, 2014
Status800 - REGISTERED AND RENEWED
Status DateWednesday, October 29, 2025
Registration Number4780600
Registration DateTuesday, July 28, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis and ankylosing spondylarthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 22, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI BIOTECHNOLOGY
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressGentilly 94250
FR
Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Thursday, September 18, 2014NEW APPLICATION ENTERED
Monday, September 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 1, 2014ASSIGNED TO EXAMINER
Saturday, November 1, 2014SUSPENSION LETTER WRITTEN
Saturday, November 1, 2014LETTER OF SUSPENSION E-MAILED
Saturday, November 1, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 20, 2015ASSIGNED TO LIE
Monday, March 30, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 14, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, July 28, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 12, 2021TEAS SECTION 8 RECEIVED
Tuesday, November 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, November 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sunday, July 28, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 10, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, October 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 29, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 29, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, October 29, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

kevzara diseases arthritis ankylosing spondylarthritis rheumatoid inflammatory treatment autoimmune pharmaceutical products